e-Profile Login and ID Quick Search
News
New Jersey State Board of Pharmacy and State’s Attorney General Partner to Provide Pharmacies With Security Best Practice Guidelines
Best practices for pharmacy security guidelines have been developed by the New Jersey State Board of Pharmacy and the state’s Attorney General to assist pharmacies in preventing drug theft and diversion.
NABP Supports Federal Legislation Creating New Category of Manufacturer Under FDA Oversight, While Maintaining Board of Pharmacy Authority Over Compounding Pharmacies
In testimony presented at a United States Senate Committee Hearing, NABP expressed its support of draft legislation that would create a new category of manufacturer to include entities that engage in large-scale production of sterile non-patient-specific drugs for distribution.
Products Produced by The Compounding Shop Should Be Quarantined Due to Lack of Sterility Assurance, Warns FDA
Medications produced and distributed by The Compounding Shop of St Petersburg, FL, should not be administered to patients and should be quarantined, warns FDA.
Colorado Deploys NABP PMP InterConnect; 15 States Now Sharing PMP Data
The Colorado Electronic Prescription Drug Monitoring Program has now deployed the NABP PMP InterConnect®, bringing the total number of live participating state prescription monitoring programs (PMPs) to 15.
NABPLAW Online Now Includes Laws and Regulations of Guam, Puerto Rico, and the Virgin Islands
The complete pharmacy acts and regulations of Guam, Puerto Rico, and the Virgin Islands are now included in NABPLAW ® Online.
NABP Updates VAWD Criteria, Continuing Efforts to Help Secure the Integrity of US Drug Supply Chain for the Protection of Public Health
To further protect the integrity of the United States drug supply chain, the National Association of Boards of Pharmacy® (NABP®) has updated the criteria for the Association’s Verified-Accredited Wholesale Distributors® (VAWD®) accreditation program.
USP Prescription Container Labeling Chapter is Now the Official Standard
The United States Pharmacopeia (USP) General Chapter <17> Prescription Container Labeling, published in the USP 36–NF 31, became an official standard on May 1, 2013.
US Senate Committee Proposes Legislation to Create Compounding Manufacturer Category to Be Under FDA Regulation
Federal lawmakers have drafted legislation that would create a new category of drug compounders, “compounding manufacturers,” to be regulated by Food and Drug Administration (FDA).
Sixth DEA Take-Back Day Collects Over 740,000 Pounds of Unneeded Medication, Helping to Prevent Diversion and Abuse
The Drug Enforcement Administration's (DEA) sixth National Prescription Drug Take-Back Day on April 27, 2013, collected twice the amount of unneeded and expired medications for safe disposal than the previous DEA take-back event six months ago.
NABP Updates VAWD Criteria, Continuing Efforts to Help Secure the Integrity of US Drug Supply Chain for the Protection of Public Health
To further protect the integrity of the United States drug supply chain, the National Association of Boards of Pharmacy® (NABP®) has updated the criteria for the Association’s Verified-Accredited Wholesale Distributors® (VAWD®) accreditation program.
FPGEC and FPGEE Fees to Increase Starting in July
Effective July 1, 2013, the application fees for the Foreign Pharmacy Graduate Examination Committee (FPGEC) certification, which includes taking the Foreign Pharmacy Graduate Equivalency Examination (FPGEE), will increase.
